Chris Shaffer, PharmD, PHD
Director, Pediatric Clinical Pharmacology Program, Child Health Research Institute, Associate Professor | University of Nebraska Medical Center
Dr. Shaffer’s is Director of the Pediatric Clinical Pharmacology Program within the Child Health Research Institute. The Pediatric Clinical Pharmacology Program translates pediatric pharmacokinetic, pharmacodynamic and pharmacogenomic research into clinical practice. As a collaboration between the UNMC Colleges of Pharmacy and Medicine, Children’s Hospital & Medical Center and CHRI, the goal of the program is to work in partnership to study and optimize medication therapy in pediatric patients.
Pain Management Grants
2020-2021
A pilot study using pharmacogenomic screening to optimize pain medications in pediatric neuro-oncology patients.
$21,000
Update from Dr. Shaffer | March 2024 | This pilot study will examine the relationship between genetics and pharmacology to recommend a “personalized medicine” approach for patients and clinicians.
• A new genotyping vendor has been selected and the MTA contract is being finalized.
• IRB modifications with the involvement of Dr. Starr as medical geneticist is complete and under review.
• Marketing material has been rebranded with new Children’s information and submitted to IRB
• Study Protocol Review with medical team is being scheduled.
• Anticipate study enrollment to begin in May.